Article

Evidence for Balancing Selection from Nucleotide Sequence Analyses of Human G6PD

Department of Biology, University of Maryland, College Park, MD 20742, USA.
The American Journal of Human Genetics (Impact Factor: 10.99). 12/2002; 71(5):1112-28. DOI: 10.1086/344345
Source: PubMed

ABSTRACT Glucose-6-phosphate dehydrogenase (G6PD) mutations that result in reduced enzyme activity have been implicated in malarial resistance and constitute one of the best examples of selection in the human genome. In the present study, we characterize the nucleotide diversity across a 5.2-kb region of G6PD in a sample of 160 Africans and 56 non-Africans, to determine how selection has shaped patterns of DNA variation at this gene. Our global sample of enzymatically normal B alleles and A, A-, and Med alleles with reduced enzyme activities reveals many previously uncharacterized silent-site polymorphisms. In comparison with the absence of amino acid divergence between human and chimpanzee G6PD sequences, we find that the number of G6PD amino acid polymorphisms in human populations is significantly high. Unlike many other G6PD-activity alleles with reduced activity, we find that the age of the A variant, which is common in Africa, may not be consistent with the recent emergence of severe malaria and therefore may have originally had a historically different adaptive function. Overall, our observations strongly support previous genotype-phenotype association studies that proposed that balancing selection maintains G6PD deficiencies within human populations. The present study demonstrates that nucleotide sequence analyses can reveal signatures of both historical and recent selection in the genome and may elucidate the impact that infectious disease has had during human evolution.

Download full-text

Full-text

Available from: Alain Froment, Jul 30, 2015
1 Follower
 · 
108 Views
  • Source
    • "In their work, Fumagalli and coworkers [9] also indicated that the effect of distinct pathogens can at least in part be disentangled, although infectious agents were grouped into macrocategories (i.e., viruses, bacteria, helminths, and protozoa). Indeed, in his observations about thalassemia, Haldane chose a lucky rare example: the specific characteristics of Plasmodium infection and the strong selective pressure the parasite exerted allowed to draw a direct link between the infectious agent and specific loci showing very strong evidence of natural selection (e.g., DARC and G6PD [10] [11]). This has proved unfeasible for the large majority of human genes, whereby signatures of natural selection are described, but the underlying selective pressure (i.e., the specific pathogen) remains unknown. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Infectious diseases and epidemics have always accompanied and characterized human history, representing one of the main causes of death. Even today, despite progress in sanitation and medical research, infections are estimated to account for about 15% of deaths. The hypothesis whereby infectious diseases have been acting as a powerful selective pressure was formulated long ago, but it was not until the availability of large-scale genetic data and the development of novel methods to study molecular evolution that we could assess how pervasively infectious agents have shaped human genetic diversity. Indeed, recent evidences indicated that among the diverse environmental factors that acted as selective pressures during the evolution of our species, pathogen load had the strongest influence. Beside the textbook example of the major histocompatibility complex, selection signatures left by pathogen-exerted pressure can be identified at several human loci, including genes not directly involved in immune response. In the future, high-throughput technologies and the availability of genetic data from different populations are likely to provide novel insights into the evolutionary relationships between the human host and its pathogens. Hopefully, this will help identify the genetic determinants modulating the susceptibility to infectious diseases and will translate into new treatment strategies.
    03/2013; 2013:204240. DOI:10.1155/2013/204240
  • Source
    • "Wood et al. (2005) 38–120 950–3000 — Modiano et al. (2008) E 100.3 (62–222) 2508 (1550–5550) 0.079 (0.035–0.099) Ohashi et al., 2004 G6PD A- 254.3 6357 (3840–11 760) 0.044 Tishkoff et al. (2001) A- 93 2325 (1200–3862) — Sabeti et al. (2002) A- 1800 45 000 (25 000–65 000) — Verrelli et al. (2002) A- 40 1000 0.25 Slatkin (2008) Med 133.2 3330 (1600–6640) 0.034 Tishkoff et al. (2001) Med 400 10 000 (0–35 000) — Verrelli et al. (2002) Mahidol 63 1575 0.23 Louicharoen et al. (2009) Duffy ES (null) 1323 33 075 (6500–97 200) — Hamblin and Di Rienzo, 2000 ES (null) 310 7750 (3625–13 125 — Seixas et al. (2002) ES (null) 490 12 250 (4250–26 500) — Seixas et al. (2002) ABO O01 — 1.15 million — Calafell et al. (2008) O02 — 2.5 million — Calafell et al. (2008) HLA-B B53 100 2500 0.028* Hill et al., 1991 B53 86 2150 0.041* This paper "
    [Show abstract] [Hide abstract]
    ABSTRACT: The high mortality and widespread impact of malaria have resulted in this disease being the strongest evolutionary selective force in recent human history, and genes that confer resistance to malaria provide some of the best-known case studies of strong positive selection in modern humans. I begin by reviewing JBS Haldane's initial contribution to the potential of malaria genetic resistance in humans. Further, I discuss the population genetics aspects of many of the variants, including globin, G6PD deficiency, Duffy, ovalocytosis, ABO and human leukocyte antigen variants. Many of the variants conferring resistance to malaria are 'loss-of-function' mutants and appear to be recent polymorphisms from the last 5000-10 000 years or less. I discuss estimation of selection coefficients from case-control data and make predictions about the change for S, C and G6PD-deficiency variants. In addition, I consider the predicted joint changes when the two β-globin alleles S and C are both variable in the same population and when there is a variation for α-thalassemia and S, two unlinked, but epistatic variants. As more becomes known about genes conferring genetic resistance to malaria in humans, population genetics approaches can contribute both to investigating past selection and predicting the consequences in future generations for these variants.
    Heredity 03/2011; 107(4):283-304. DOI:10.1038/hdy.2011.16 · 3.80 Impact Factor
  • Source
    • "This observation may hypothetically suggest that loss of muscle genes during the evolution of the human lineage may have been accompanied by an increased capability of the remaining genes to adapt to changing environmental conditions with closely similar structures (Ayroles et al. 2009). Overdominance had already been reported in genes involved in human diseases, such as the gene for haemoglobin in relation to sickle-cell anaemia (Allison 1956), the malaria-resistant associated genes such as G6PD (Verrelli et al. 2002), or the gene associated with the prion disease ''kuru'' (Mead et al. 2003), as well as in common disorders such as diabetes mellitus (Cox et al. 1999). The evidence for overdominance should be reconsidered in terms of both statistical confirmation and biological plausability once a causative gene will be identified. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Autosomal dominant Emery-Dreifuss muscular dystrophy is caused by mutations in LMNA gene encoding lamins A and C. The disease is characterized by early onset joint contractures during childhood associated with humero-peroneal muscular wasting and weakness, and by the development of a cardiac disease in adulthood. Important intra-familial variability characterized by a wide range of age at onset of myopathic symptoms (AOMS) has been recurrently reported, suggesting the contribution of a modifier gene. Our objective was to identify a modifier locus of AOMS in relation with the LMNA mutation. To map the modifier locus, we genotyped 291 microsatellite markers in 59 individuals of a large French family, where 19 patients carrying the same LMNA mutation, exhibited wide range of AOMS. We performed Bayesian Markov Chain Monte Carlo-based joint segregation and linkage methods implemented in the Loki software, and detected a strong linkage signal on chromosome 2 between markers D2S143 and D2S2244 (211 cM) with a Bayes factor of 28.7 (empirical p value = 0.0032). The linked region harbours two main candidate genes, DES and MYL1 encoding desmin and light chain of myosin. Importantly, the impact of the genotype on the phenotype for this locus showed an overdominant effect with AOMS 2 years earlier for the homozygotes of the rare allele and 37 years earlier for the heterozygotes than the homozygotes for the common allele. These results provide important highlights for the natural history and for the physiopathology of Emery-Dreifuss muscular dystrophy.
    Human Genetics 11/2010; 129(2):149-59. DOI:10.1007/s00439-010-0909-1 · 4.52 Impact Factor
Show more